| Chad Leblanc, DO | |
|
1034 North 500 West, Provo, UT 84604 | |
| (801) 373-7850 | |
| Not Available |
| Full Name | Chad Leblanc |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 1034 North 500 West, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588604532 | NPI | - | NPPES |
| 58708721200001 | Other | BCBS | |
| 58708721202001 | Other | UT | BCBS |
| P00295439 | Other | RAILROAD MEDICARE | |
| P00420439 | Other | UT | RAIL ROAD MEDICARE |
| 1588604532 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 58708721204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| American Fork Hospital | American fork, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Valley Emergency Physicians Lc | 4789630401 | 16 |
News Archive
Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.
Assembly Pharmaceuticals and BioCrossroads today announced that the BioCrossroads Indiana Seed Fund II has made an investment in Assembly Pharmaceuticals. Assembly is developing novel drugs for the treatment and potential cure of chronic hepatitis B virus (HBV) infection.
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By analyzing genetic and phenotypic changes in antibiotic-resistant strains of E. coli, researchers at the RIKEN Quantitative Biology Center in Japan have revealed a common set of features that appear to be responsible for the development of resistance to several types of antibiotics.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
› Verified 9 days ago
| Entity Name | Utah Valley Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649204553 PECOS PAC ID: 2860390879 Enrollment ID: O20040727000274 |
News Archive
Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.
Assembly Pharmaceuticals and BioCrossroads today announced that the BioCrossroads Indiana Seed Fund II has made an investment in Assembly Pharmaceuticals. Assembly is developing novel drugs for the treatment and potential cure of chronic hepatitis B virus (HBV) infection.
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By analyzing genetic and phenotypic changes in antibiotic-resistant strains of E. coli, researchers at the RIKEN Quantitative Biology Center in Japan have revealed a common set of features that appear to be responsible for the development of resistance to several types of antibiotics.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
› Verified 9 days ago
| Entity Name | North Valley Emergency Physicians Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134177876 PECOS PAC ID: 4789630401 Enrollment ID: O20050325000297 |
News Archive
Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.
Assembly Pharmaceuticals and BioCrossroads today announced that the BioCrossroads Indiana Seed Fund II has made an investment in Assembly Pharmaceuticals. Assembly is developing novel drugs for the treatment and potential cure of chronic hepatitis B virus (HBV) infection.
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By analyzing genetic and phenotypic changes in antibiotic-resistant strains of E. coli, researchers at the RIKEN Quantitative Biology Center in Japan have revealed a common set of features that appear to be responsible for the development of resistance to several types of antibiotics.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chad Leblanc, DO Po Box 10, Spanish Fork, UT 84660-0010 Ph: (866) 898-7136 | Chad Leblanc, DO 1034 North 500 West, Provo, UT 84604 Ph: (801) 373-7850 |
News Archive
Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2, the coronavirus that causes COVID-19.
Assembly Pharmaceuticals and BioCrossroads today announced that the BioCrossroads Indiana Seed Fund II has made an investment in Assembly Pharmaceuticals. Assembly is developing novel drugs for the treatment and potential cure of chronic hepatitis B virus (HBV) infection.
Treating bacterial infections with antibiotics is becoming increasingly difficult as bacteria develop resistance not only to the antibiotics being used against them, but also to ones they have never encountered before. By analyzing genetic and phenotypic changes in antibiotic-resistant strains of E. coli, researchers at the RIKEN Quantitative Biology Center in Japan have revealed a common set of features that appear to be responsible for the development of resistance to several types of antibiotics.
"The cholera bacterium has undergone important mutations in recent years, causing longer outbreaks of the disease with increased fatalities, researchers reported on Wednesday," Reuters reports. "In a package of papers published in the journal PLoS Neglected Tropical Diseases, they said mass vaccinations should be considered as a solution even after outbreaks have begun," the news service writes (Lyn, 1/26).
At a High-Level Meeting on Innovation for Elimination of Mother to Child Transmission (EMTCT) on Friday in Washington, D.C., "HIV experts, business leaders, aid agencies and ambassadors of 22 priority countries - home to 90 percent of new HIV infections among children -" agreed that strategic innovations are necessary to curb the spread of the virus from women to their children, PANA/Afrique en Linge reports.
› Verified 9 days ago
Adam R Krommenhoek, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 | |
Dr. Christopher Nathan Johnson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 | |
Craig P Patten, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 North 500 West, Provo, UT 84604 Phone: 801-373-7850 | |
Robert D Christensen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 | |
Andrew Pressman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 | |
Mr. Tanner Lee Frey, PHYSICIAN ASSISTANT Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-358-1076 | |
Dr. Cameron Royall, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-362-4119 |